Package 55111-170-01

{"route": ["ORAL"], "spl_id": "0de300a2-2952-29fb-80ad-7b2cab86e101", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0355111170013"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["da457b34-ca08-60df-045b-1ae80d2f7e71"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (55111-170-01)", "package_ndc": "55111-170-01", "marketing_start_date": "20010131"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (55111-170-05)", "package_ndc": "55111-170-05", "marketing_start_date": "20010131"}], "brand_name": "Oxaprozin", "product_id": "55111-170_0de300a2-2952-29fb-80ad-7b2cab86e101", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "55111-170", "generic_name": "Oxaprozin", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075855", "marketing_category": "ANDA", "marketing_start_date": "20010131", "listing_expiration_date": "20261231"}